Modafinil Australia
is primarily used for the treatment of excessive sleepiness associated with narcolepsy. It has also been studied for other neurological and medical disorders that involve cognitive dysfunction, including multiple sclerosis, idiopathic Parkinson's disease, chronic fatigue syndrome, obstructive sleep apnea, and fibromyalgia. Modafinil has been shown to be more effective than placebo at improving cognitive functions in these conditions. It has a unique mechanism of action compared to traditional psychostimulants. It does not elicit the same dopamine elevation in the nucleus accumbens of the brain that is responsible for the addictive properties of some other drugs.